ASCO GUIDELINES Bundle

Ovarian Masses and Treatment of Epithelial Ovarian Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475493

Contents of this Issue

Navigation

Page 1 of 37

2 Key Recommendations Diagnostic Strategies ➤ General practitioners should perform a clinical assessment, family history, and where available, aid diagnosis by ultrasound (abdominal and transvaginal ultrasound (TVU), Doppler-enhanced) and/or contrast-enhanced computed tomography (CT) of abdomen and pelvis (with or without thorax). ➤ In postmenopausal women with symptoms of ovarian cancer, cancer antigen 125 (CA-125) value can assist in diagnosis. ➤ Ovarian cancer is diagnosed with histologic confirmation in all settings. ➤ CT-guided biopsy or laparoscopy (with sufficient resources) is preferred instead of laparotomy to obtain histologic confirmation prior to any systemic therapy. Optimal Surgery ➤ The purpose of surgery is to diagnose, stage, and/or for treatment. ➤ Ovarian cancer surgery should be performed by trained gynecologic oncologists or surgeons with oncology surgical expertise. Refer patients to highest-resourced level oncology center with oncology surgical capacity. ➤ Staging: Where feasible, patients with presumed early-stage ovarian cancer should undergo surgical staging by trained surgeon(s). In basic settings, surgical staging is not feasible, thus NOT recommended. ➤ Treatment: Women with advanced ovarian cancer (stage III and IV) should receive optimal surgical debulking to remove all visible disease to improve overall survival (OS) by trained surgeon(s). General statement about chemotherapy: Access to appropriate evidence-based chemotherapy agents, contraindications to chemotherapy, and potential side effects of chemotherapy should be evaluated and managed in every patient. Basic- resource settings that lack the capacity to provide safe administration of chemotherapy should refer patients to a higher-level center for evaluation. Limited settings without skilled capacity should refer patients to settings with access to specialized care.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Ovarian Masses and Treatment of Epithelial Ovarian Cancer